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The cryptic Streptococcus cremoris Wg2 plasmid pWV01 (1.5 megadaltons) was genetically marked with the
chloramphenicol resistance (Cmr) gene from pC194. The recombinant plasmid (pGK1, 2.4 megadaltons)
replicated and expressed Cm' in Bacillus subtilis. From this plasmid an insertion-inactivation vector was
constructed by inserting the erythromycin resistance (Em') gene from pE194 cop-6. This plasmid (pGK12, 2.9
megadaltons) contained a unique BclI site in the Emr gene and unique ClaI and HpaII sites outside both
resistance genes. It was stably maintained in B. subtilis at a copy number of approximately 5. pGK12 also
transformed Escherichia coli competent cells to Cmr and Emr. The copy number in E. coli was about 60.
Moreover, pGK12 transformed protoplasts of Streptococcus lactis. In this host both resistance genes are
expressed. pGK12 is stably maintained in S. lactis at a copy number of 3.
Lactic acid streptococci typically contain a large plasmid
DNA complement. Most of these plasmids, however, are
cryptic. Only in a few cases has a particular property been
attributed to the presence of a specific plasmid, by showing
that the plasmid and the trait were simultaneously trans-
ferred (for a review, see reference 5). The genetic transfer
mechanisms that have been shown to operate in lactic acid
streptococci are conjugation, transduction, and protoplast
fusion (5, 8, 25, 26). Recently, it has been demonstrated that
polyethylene glycol-treated protoplasts of Streptococcus
lactis subsp. diacetylactis are transfectable (10) and that
polyethylene glycol-treated protoplasts of Streptococcus
lactis are transformable by free plasmid DNA (23). The yield
of transformants per microgram of transforming plasmid
DNA was extremely low.
In this report, we describe the genetic marking of a small
cryptic Streptococcus cremoris plasmid. The recombinant
plasmids obtained replicated and were expressed in Bacillus
subtilis, Escherichia coli, and Streptococcus lactis, and they
can be used as bridge vectors between these three species.
Moreover, they can be used to establish the conditions for
further improvement of the frequency of transformation in
lactic acid streptococci.
MATERIALS AND METHODS
Bacterial strains and media. The strains used are described
in Table 1. For preparing plasmid DNAB. subtilis and E. coli
cells were grown in TY broth (28). TY broth solidified with
1.5% agar was used for plating. Chloramphenicol was used
at concentrations of 5 and 2 ,ug/ml and erythromycin was
used at concentrations of 5 and 50 p.g/ml for B. subtilis and
E. coli, respectively. M17-glucose broth and M17-glucose
agar plates (32) were used to grow Streptococcus lactis. For
Streptococcus lactis chloramphenicol and erythromycin
were used at concentrations of 5 and 1 pg/ml, respectively.
Isolation of plasmid DNA. Plasmids pE194 cop-6 and
pGL112 were isolated as described by de Vos et al. (6).
Large-scale or mini preparations of recombinant plasmids
from E. coli and ofpWV01 and recombinant plasmids from
B. subtilis were obtained by using the method of Ish-
Horowicz and Burke (19). For B. subtilis some minor
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modifications were introduced. The cells were lysed in TES
buffer (50 mM Tris-hydrochloride, 5 mM EDTA, 50 mM
NaCl, pH 8.0) containing 20% sucrose and 2 mg oflysozyme
per ml by 15 min of incubation at 0°C, followed by 15 min at
37°C. For large- or small-scale isolation of plasmid DNA
from Streptococcus lactis the method of Gasson (9) was
used.
Restriction enzyme reactions and purification of DNA frag-
ments. Restriction enzymes were used as specified by the
manufacturer. Digested DNA was analyzed in 1% horizontal
agarose (Bio-Rad Laboratories, Richmond, Calif.) gels in
TBE buffer (89 mM Tris-borate, 89 mM boric acid, 2 mM
EDTA, 0.5 jig of ethidium bromide per ml, pH 8.0). Bacte-
riophage SPP1 DNA digested with EcoRI served as a DNA
size marker. DNA restriction enzyme fragments used for
cloning were separated in agarose gels and were isolated and
purified from the gels with a DEAE membrane (Schleicher &
Schuell, Dassel, West Germany) according to the instruc-
tions of the supplier.
Molecular cloning and transformation. Vector molecules
were mixed with the restriction fragments to be inserted at a
ratio ofapproximately 1:2 at a concentration of 100 ,ug/ml in
TE buffer (10 mM Tris-hydrochloride, 1 mM EDTA, pH
7.4). After heating for 5 min at 68°C, the samples were
adjusted to ligase buffer (10 mM Tris-hydrochloride, 10 mM
MgC92, 10 mM dithiothreitol, 1 mM ATP, 50 mM NaCl, pH
7.4). T4 DNA ligase was added, and the mixtures were
incubated for 2 h at 7°C. After fivefold dilution with ligase
buffer, incubation was continued for about 18 h at 7°C.
Ligated DNA preparations were used to transform proto-
plasts ofB. subtilis 8G5 by the method of Chang and Cohen
(4). Transformants were selected on DM3 plates containing 5
,ug of chloramphenicol or erythromycin per ml. B. subtilis
8G5 was grown to competence essentially as described by
Bron and Venema (3). After exposure to the DNA, the
cultures were diluted twofold with TY broth and were
incubated for 90 min to allow for expression. Transformants
were selected on TY plates containing 5 jLg ofchlorampheni-
col per ml or 5 ,ug oferythromycin per ml or both. Transfor-
mation of E. coli was performed by the method of Mandel
and Higa (24). Protoplast transformation of Streptococcus
lactis MG1363 was done as described by Kondo and McKay
(23), except that 25% sucrose was used for stabilization of
the protoplasts.
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TABLE 1. Bacterial strains and plasmids
Strain designation Chromosomal Plasmid Plasmid Mol wt Source and remarks Reference markers marker(s) (X 106)
B. subtilis
8G5 trp tyr his ade Laboratory collection, Bron 3
met rib ura nic and Venema
8G5(pWV01) pWVOl 1.5 33
8G5(pGL112) pGL112 Cmr Kmr 2.4 Plasmid; laboratory collection,
Bron and Luxen"
8G5(pE194 cop-6) pE194 cop-6 Emr 2.3 Plasmid 34
8G5(pGK1) pGK1 Cmr 2.4 This work
8G5(pGK11) pGK11 Cmr 2.1 This work
8G5(pGK12) pGK12 Cmr Emr 2.9 This work
E. coli
BHB2600 803 supE+ 14
supF+
r,k- mk+
met
BHB2600(pGK12) pGK12 Cmr Emr 2.9 This work
Streptococcus lactis
MG1363 9
MG1363(pGK12) pGK12 cmr Emr 2.9 This work
a pGL112 is a chimera between pC194 and pUB110 constructed by S. Bron and E. Luxen (unpublished data). It contains the replication functions and the
kanamycin resistance (Kmr) gene of pUB110 and the Cmr gene of pC194.
Plasmid copy number determination. B. subtilis was grown
overnight in minimal medium consisting of Spizizen minimal
salts (31) plus glucose (0.5%), casein hydrolysate (0.02%),
and growth factors (14 Fig each per ml, except for vitamins;
vitamins, 0.4 p.g/ml). M9-glucose minimal medium (1) sup-
plemented with 0.02% casein hydrolysate and growth factors
at concentrations of 20 pLg/ml was used to grow E. coli.
Streptococcus lactis was grown to late exponential phase in
M17-glucose broth. All three media were supplemented with
5 ,uCi of [methyl-3H]thymidine (New England Nuclear
Corp., Boston, Mass.) per ml and the appropriate antibiot-
ics. Total cell and plasmid DNA was isolated from 2-ml
portions of the cultures by scaling down the plasmid DNA
isolation procedure described by de Vos et al. (6) 100-fold.
For Streptococcus lactis 10 ml of the culture was used with
lysozyme at a concentration of 5 mg/ml. After the incubation
step with pronase, the lysates were placed at -80°C until
frozen, heated for 5 min at 65°C, and agitated for two 30-s
intervals with a Vortex mixer (top speed). Chromosomal and
plasmid DNAs in the lysates were separated in a 0.8%
agarose gel. The ethidium bromide-stained bands were ex-
cised and dissolved in a boiling water bath. After addition of
15 ml of Hydroluma (Lumac Systems Inc., Titusville, Pa.),
the samples were counted in a Mark II liquid scintillation
counter (Nuclear-Chicago Corp., Des Plaines, Ill.).
RESULTS
Genetic marking ofpWV01. The physical maps ofpGL112,
pE194 cop-6, and pWV01 are presented in Fig. 1, together
with the cloning strategy. pGL112 was digested with MboI,
and the fragments were separated in a 1% agarose gel. The
largest fragment comprises the pC194 sequence between
residues 973 and 2,004 on the sequence of Horinouchi and
Weisblum (17). It contains the entire chloramphenicol resist-
ance (Cmr) gene but lacks the origin of replication of pC194;
it does not contain the origin of replication of pUB110 (29).
This fragment was purified and ligated into the unique MboI
site of pWV01, and the ligation mixture was used to trans-
form protoplasts of B. subtilis. Cmr regenerants were ob-
tained, and the plasmid of one of these, designated pGK1
(2.4 megadaltons [Md]), was characterized by restriction
enzyme analyses. Digestion with MboI yielded two frag-
ments, the largest of which migrated to the same position as
the linear plasmid pWV01 (1.5 Md). The second fragment
(0.9 Md) corresponded to the largest MboI fragment of
pGL112 (Fig. 2, lanes 1 through 3). Digestion of pGK1 with
ClaI generated the following two fragments: the unchanged
small ClaI fragment of pWVO1 (Fig. 1) and a 2.1-Md frag-
ment which resulted from the insertion of the Cmr gene-
containing fragment of pGL112 into the large 1.2-Md ClaI
fragment of pWV01 (Fig. 3, lanes 1 and 2). The small ClaI
fragment was deleted from pGK1 in vitro by cutting with
ClaI. After isolation and religation of the largest fragment,
protoplast transformation of B. subtilis with the ligation
mixture yielded Cmr regenerants. These cells contained the
deletion derivative of pGK1, which was designated pGK11
(2.1 Md) and had a unique ClaI site (Fig. 3, lane 3). As
pGK1, this plasmid also contained a unique HpaII site,
residue 973 on the sequence of Horinouchi and Weisblum
(17), providing additional evidence that both recombinant
plasmids carried the specific pGL112 MboI fragment (Fig. 3,
lane 4). The orientation of this fragment in pGK1 was
deduced from double digestion with ClaI and HpaII (data
not shown). The fact that the small ClaI fragment of pGK1
was deletable without impairing plasmid replication suggest-
ed that the remaining ClaI site in pGK11 could be used for
cloning.
Construction of an insertion-inactivation vector. In order to
examine the usefulness of the ClaI site for insertion and to
further improve these pWV01-derived recombinant plasmids
for cloning purposes, an insertion-inactivation vector was
constructed from pGK11 (Fig. 1). To do this, pE194 cop-6
was digested with ClaI and HpaII, and the largest fragment
was isolated. This fragment, ranging from residues 1,939 to
3,137 on the sequence of Horinouchi and Weisblum (16),
contains the erythromycin resistance (Emr) gene and is
devoid ofthe replication origin ofpE194 cop-6. It was ligated
into the unique ClaI site of pGK11. Transformation of
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protoplasts ofB. subtilis with the ligation mixture resulted in
Cmr Emr transformants. One of these was selected and
contained a 2.9-Md plasmid. The results of a restriction
enzyme analysis ofthis plasmid, designated pGK12, togeth-
er with the parental plasmid pGK11 are shown in Fig. 4.
Upon cleavage with MboI, both plasmids gave rise to a 0.9-
Md fragment, the Cmr gene-containing fragment ofpGL112.
The upper band in Fig. 4, lane 4, represents the deleted form
ofpWV01. This fragment was enlarged in pGK12 due to the
insertion of the Emr gene-bearing fragment of pE194 cop-6.
Because this insertion contained two MboI sites, two addi-
tional bands were generated from pGK12 (Fig. 4, lane 3). As
aconsequence ofthe ligation ofthe ClaI-HpaII insertion into
ClaI-linearized pGK11, plasmid pGK12 still contained a
unique ClaI site (lane 1), as well as a unique HpaII site.
pGK12 was linearized by BclI (lane 2), confirming the
identity of the insertion. The Bcll site is situated in the
coding sequence of the Emr gene, and insertion of DNA
fragments into this site inactivates Emr (15).
Replication ofthe recombinant plasmids in E. coli. The fact
that the Cmr and Emr genes which are used to genetically
mark plasmid pWV01, are both expressed in E. coli (2, 11,
12) made it feasible to investigate whether the recombinant
plasmids also replicated in this organism. To do this, compe-
tent cells of E. coli BHB2600 were exposed to plasmid
pGK12. After allowing time for expression, dilutions were
plated onto TY agar plates containing 2 ,ug ofchlorampheni-
col per ml and 50 ,ug oferythromycin per ml. After overnight
incubation small colonies appeared. These colonies con-
tained plasmid DNA indistinguishable from pGK12 isolated
from B. subtilis with respect to size and restriction enzyme
patterns (data not shown). The combination of 2 ,ug of
chloramphenicol per ml and 50 ,ug of erythromycin per ml
was appropriate to select for transformed E. coli BHB2600
cells. With erythromycin or chloramphenicol alone, 100 ,ug
or more of erythromycin per ml or up to 10 ,ug of chloram-
phenicol per ml is needed for selection, depending on the E.
coli strain used. pGK12 isolated from E. coli transformed
competent B. subtilis cells to Cmr and Emr with normal
frequencies. Transformation of B. subtilis to Cmr Emr re-
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FIG. 1. Cloning strategy and restriction maps of plasmids pGL112, pE194 cop-6, pGK1, pGK11, and pGK12. The origins of plasmid
segments are indicated in the key. For reasons of clarity only those sites relevant for the construction and properties of the recombinant
vectors are shown. The concentric arcs span the fragments used for insertion. For details, see the text.
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FIG. 2. MboI restriction fragment patterns after electrophoresis
in a 1% agarose gel. Lane 1, pWV01; lane 2, pGK1; lane 3, pGL112.
Lane 4 is a size reference (EcoRI digest of phage SPP1 DNA). For
the molecular weights ofthe DNA size standards, see reference 27.
quired induction of the cells with 50 ng of erythromycin per
ml during the expression time. Without induction transform-
ants could only be scored on plates containing chloramphen-
icol alone.
Replication and expression ofpGK12 in Streptococcus lactis.
To examine whether the markers carried by the pWV01-
derived vectors can be expressed in lactic acid streptococci,
pGK12 isolated from B. subtilis was used to transform
protoplasts of Streptococcus lactis MG1363, a plasmid-free
strain (9). Protoplasts of Streptococcus lactis MG1363 were
prepared as described by Kondo and McKay (23) and treated
with 1 ,ug ofpGK12. After 2 h ofincubation at 30°C to allow
time for expression, dilutions were plated onto sucrose-M17
plates containing either 5 ,ug ofchloramphenicol per ml or 1
,ug of erythromycin per ml. After incubation at 30°C for
about 7 to 10 days, colonies appeared on both types of
plates. Cmr colonies were also Emr and vice versa. In a
typical experiment regeneration was 10%, and the numberof
transformants per microgram ofpGK12 was about 0.5 x 104.
Transformant colonies contained a plasmid which had the
same molecular weight and restriction enzyme patterns as
pGK12 (data not shown).
Copy numbers and plasmid stability. The copy number of
pGK12 in the three hosts was determined (Table 2). In both
Streptococcus lactis and B. subtilis pGK12 was maintained
1 2 3 4 5
FIG. 3. Agarose (1%) gel electrophoresis of plasmids pWVO1
(lane 1), pGK1 (lane 2), and pGK11 (lane 3) digested with ClaI. Lane
4, pGK11 plus HpaII; lane 5, phage SPP1 DNA plus EcoRI. (27).
at a low copy number; in B. subtilis it was about 5, which is
in good agreement with the value found for pWV01 in B.
subtilis (33). The copy number of pGK12 in E. coli was
approximately 10 times higher than that in B. subtilis. Table
3 shows that pGK12 was stably maintained in Streptococcus
lactis and B. subtilis in the absence of selective pressure.
This is in contrast to E. coli, which lost pGK12 at a
frequency of 48%. pGK12 conferred resistance to at least 2
mg of erythromycin per ml in all three organisms. The
resistance levels for chloramphenicol were approximately 5,
10, and 50 ,ug/ml in Streptococcus lactis, E. coli, and B.
subtilis, respectively.
DISCUSSION
During the construction of the recombinant resistance
vectors from the cryptic plasmid pWV01, care was taken
that, apart from the antibiotic resistance genes, no plasmid
replication functions from pGL112 or pE194 cop-6 were
inserted. Both the antibiotic resistance phenotype of the
cells carrying the recombinant plasmids and the restriction
enzyme analysis of the plasmids confirmed that only the
desired fragments had been ligated into pWV01. In addition,
the presence of pWV01 sequences was confirmed by South-
ern hybridization (30) of the recombinants, using pWV01
isolated from Streptococcus cremoris Wg2 as a probe (data
not shown). The finding that the recombinant plasmids had
the same low copy number as pWV01 in B. subtilis (33)
supports the conclusion that replication is directed by
pWV01 sequences.
The construction of pGK1 showed that the MboI site of
pWV01 can be used for cloning, as can the unique HpaII site
located on the inserted fragment carrying the Cmr gene. In
fact, this HpaII site is a hybrid site, which arose in the
construction of pGL112 from pC194 and pUB110 (Fig. 1).
The small ClaI fragment from pGK1 could be deleted,
indicating that it does not contain sequences of vital impor-
tance for plasmid maintenance and replication in B. subtilis
and that both ClaI sites of pWV01 can be used for DNA
insertion. The remaining unique ClaI site generated in the
construction of pGKll was used to insert the Emr gene of
pE194 cop-6, resulting in the double-resistance vector
pGK12. pGK12 contains unique sites for ClaI, HpaII, and
BcIl. The first two sites are located outside both resistance
genes and can be used for insertions of foreign DNA
fragments generated by HpaII, ClaI, and TaqI. The BclI site
is located within the Emr gene, and insertion of DNA in this
site inactivates the gene (15). Therefore, pGK12 can be used
for cloning by insertional inactivation offragments produced
by BglII, BclI, BamHI, and MboI by first selecting for Cmr
FIG. 4. Agarose (1%) gel electrophoresis of restriction enzyme
digests of plasmids pGK11 and pGK12. Lane 1, pGK12 plus ClaI;
lane 2, pGK12 plus BcIl; lane 3, pGK12 plus MboI; lane 4, pGK11
plus MboI; lane 5, phage SPP1 DNA plus EcoRI. (27).
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transformants. An additional important feature of the Emr
gene is that expression of cloned DNA can be promoted in
both B. subtilis and E. coli through induction with subinhibi-
tory levels of erythromycin (12, 13, 34). Insertion with
inactivation of Cmr is also possible by removing ClaI-HpaII
fragment B, yielding a Cms Emr phenotype. The small MboI-
ClaI fragment originating from pWV01 is deletable (unpub-
lished data). Moreover, pGK12 offers the possibility of
directional cloning with Emr inactivation; cleavage of the
plasmid with BclI and ClaI results in a vector fragment with
different protruding ends.
Little information is available concerning the replication
of plasmids of gram-positive bacteria in the gram-negative
organism E. coli. The gram-positive replication functions in
all ofthese instances originated from Staphylococcus aureus
(2, 11). In the case of a chimera between pLS1 (a Streptococ-
cus pneumoniae plasmid) and pBD6 (a hybrid between
Staphylococcus aureus plasmids pUB110 and pSA0501), it is
not clear which replication origin is used in E. coli (7). This
work showed that a replicon from another gram-positive
organism, pWV01 isolated from a lactic acid streptococcus,
can replicate in E. coli. An interesting difference between
pC194 (11) and pWV01 replication in E. coli is the observa-
tion that the pWV01-derived recombinants are maintained at
a copy number at least 20 times higher than that of pC194.
Recently, uptake offree DNA by protoplasts oflactic acid
streptococci has been reported. The transformation efficien-
cy of polyethylene glycol-treated protoplasts of Streptococ-
cus lactis by plasmid DNA was very low, about eight
transformants per ,ug of plasmid DNA (23). However, poly-
ethylene glycol-induced transfection of protoplasts of Strep-
tococcus lactis subsp. diacetylactis was considerably more
efficient (5 x 104 transfectants per p.g of phage DNA) (10).
These observations and recent improvements in the frequen-
cy of Streptococcus lactis protoplast transformation (L. L.
McKay, personal communication) open the possibility that
recombinant DNA technology can be applied to these organ-
isms of considerable industrial importance. The results pre-
sented here show that pWV01, a plasmid from Streptococ-
cus cremoris, replicates in Streptococcus lactis. More
important, however, is the observation that two antibiotic
resistance genes originating from Staphylococcus aureus
(18) are expressed in Streptococcus lactis. Therefore, the set
of vectors constructed from pWV01 adds an important
dimension to the dissection of the genetics of the lactic acid
streptococci. First, these vectors can be used to monitor
further improvements of the protoplast transformation sys-
TABLE 2. Estimation of pGK12 copy numbers in B. subtilis, E.
coli, and Streptococcus lactisa
Ratio of total
circular Chromosomal circular Copy
Strain
DNA DNA DNA to
Copy
(cpm) (cpm) chromosomal
~~DNA
B. subtilis 124 15,823 128 5
8G5(pGK12)
E. coli
BHB2600(pGK12) 3,723 54,319 15 62
Streptococcus lactis
MG1363(pGK12) 8,975 1,804,020 201 3
a Lysates of plasmid-carrying strains were prepared and analyzed as
described in the text. To calculate the copy numbers (plasmid molecules per
chromosome equivalent), the molecular weights of the B. subtilis, E. coli, and
Streptococcus lactis chromosomes were taken as 2.0 x 109, 2.7 x 109, and 1.7
x 109, respectively (20, 22).
TABLE 3. Plasmid stability"
No.of %Cm'
Strain colonies Ems
scored
B. subtilis 8G5(pGK12) 133 3
E. coli BHB2600(pGK12) 209 48
Streptococcus lactis MG1363(pGK12) 226 0
a An overnight broth culture supplemented with the appropriate antibiotics
was diluted 105, grown for 18 h at 37'C (30'C for Streptococcus lactis) in broth
without antibiotics, and then plated onto nonselective medium. Colonies were
replica-plated onto plates containing chloramphenicol and erythromycin.
tem in these organisms. For instance, preliminary results
suggest that liposomes enhance the protoplast transforma-
tion frequency. Second, the plasmids have some of the
desirable properties ofgood cloning vehicles; they have low
molecular weights and easily selectable antibiotic resistance
markers of which the entire nucleotide sequence is known
(16, 17). One, pGK12, can be used to select for recombinant
plasmids by insertional inactivation. Third, the plasmids are
replicated and expressed in Streptococcus lactis, as well as
in B. subtilis and E. coli, and can be used as bridge vectors
between Streptococcus lactis and the latter two species, for
which recombinant DNA technologies have been worked
out in considerable detail.
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